Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 1-10 of 12

Page
per page
  1. Lenalidomide hydrochloride
    A3547 Lenalidomide hydrochloride
    Summary: TNF-α secretion inhibitor
  2. Necrostatin 2
    A3652 Necrostatin 2
     2 Citation
    Summary: In vitro necroptosis inhibitor
      Soluble in DMSO
  3. Lenalidomide hemihydrate
    B1188 Lenalidomide hemihydrate
    Summary: TNF-α secretion inhibitor
      insoluble in H2O; insoluble in EtOH; ≥30.1 mg/mL
  4. Celastrol
    A2604 Celastrol
    Target: Proteasome
    Summary: Antioxidant, anti-inflammatory and immunosuppressive agent
      ≥22.55 mg/mL
  5. Lenalidomide (CC-5013)
    A4211 Lenalidomide (CC-5013)
    Target: angiogenesis
    Summary: Antineoplastic agent,inhibits angiogenesis
      insoluble in EtOH; insoluble in H2O; ≥100.8 mg/mL
  6. Pomalidomide (CC-4047)
    A4212 Pomalidomide (CC-4047)
    Summary: Immunomodulator,antumor/anti-angiogenic
      insoluble in EtOH; insoluble in H2O; ≥7.5 mg/mL
  7. Necrostatin-1
    A4213 Necrostatin-1
     5 Citation
    Target: RIP kinases
    Summary: RIP1 inhibitor
      insoluble in H2O; ≥12.97 mg/mL
  8. Thalidomide
    A4216 Thalidomide
    Target: Ubiquitin E3 Ligases
    Summary: Immunomodulatory agent,sedative drug,angiogenesis inhibitor
      insoluble in H2O; insoluble in EtOH; ≥11.8 mg/mL
  9. CPI-1189
    B6109 CPI-1189
    Summary: necrosis factor (TNF) alpha inhibitor
      ≥23.4 mg/mL
  10. GSK481
    B6194 GSK481
    Summary: RIP1(Receptor Interacting Protein Kinase 1) inhibitor
      Soluble in DMSO

Items 1-10 of 12

Page
per page